(firstQuint)Treatment Evaluation of Neuromodulation for Tinnitus - Stage A2.

 Participants with chronic tinnitus will be provided with a CE marked neuromodulation device.

 Participants are randomized to one of four different treatment arms.

 The treatment period is intended for 12 weeks of use, in which different parameter settings are implemented between the first and second halves of the treatment period.

 Differences in tinnitus severity scores will be compared between and within treatment arms.

.

 Treatment Evaluation of Neuromodulation for Tinnitus - Stage A2@highlight

This is a four arm, patient subtyping and parameter optimisation study for a neuromodulation treatment for tinnitus.

